Journal for ImmunoTherapy of Cancer (Nov 2023)
2 Nilogen oncosystems’s 3D-PREDICT tumoroid model is an ex vivo precision oncology and co-clinical trial enrichment platform
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)